On March 21, Wu Jincheng, director of Shanghai Municipal Commission of economy and information technology, went to Shanghai Jienuo Biotechnology Co., Ltd. to investigate the development and application of covid-19 pneumonia rapid nucleic acid detection products. He pointed out that he hoped that enterprises would speed up the development and application of relevant products and make positive contributions to epidemic prevention and control and people’s life and health. Genobio is subordinate to China Meheco Group Co.Ltd(600056) Group Co., Ltd. China Biotechnology Co., Ltd. the covid-19 rapid nucleic acid detection product developed by genobio Shenghua has obtained CE certification and several national registration certificates.